출판 : MarketsandMarkets（마켓츠앤마켓츠）출판년월 : 2022년08월
방사선 치료(Radiotherapy) 시장 : 유형 (제품, 서비스), 기술 (LINAC, 선형 정위, 입자 방사선 요법, 코발트 60 원격 치료), 절차 (IMRT, IGRT, 3D-CRT, LDR, HDR), 용도 (전립선, 유방, 폐), 최종 사용자 (병원) – 2027 년까지의 세계 예측
Radiotherapy Market by Type (Product, Service), Technology (LINAC, Stereotactic LINAC, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) – Global Forecasts to 2027
| 페이지수 | 295 |
| 도표수 | 273 |
| 구성 | 영문조사보고서 |
| 가격 |
The global radiotherapy market is valued at USD 6.3 billion in 2022 and is expected to reach USD 8.1 billion by 2027, at a CAGR of 5.1% during the forecast period. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, growing awareness of the benefits of radiotherapy and the increasing use of particle therapy for cancer treatment are other factors driving the growth of this market.
세계 방사선 치료 시장은 예측 기간 동안 5.1%의 CAGR로 2022년 63억 달러에서 2027년 81억 달러에 이를 것으로 예상됩니다. 방사선 요법의 기술 발전과 암 발병률 증가는 이 시장의 성장을 이끄는 주요 요인입니다. 또한, 방사선 요법의 이점에 대한 인식 증가와 암 치료를 위한 입자 요법의 사용 증가는 이 시장의 성장을 이끄는 다른 요인입니다.
However, inadequate healthcare infrastructure, especially in emerging countries and shortage of skilled oncologists and radiologists hinders the growth of this market. In addition to this, high cost of radiotherapy devices, and high complexities associated with radiotherapy treatment are the factors expected to restrain the growth of this market during the forecast period.
“Theservice segment, by type, is expected to register the highest growth rate in the global radiotherapy market during the forecast period 2022-2027”
Based on type, the radiotherapy market is segmented into products and services. In 2021, the products segment accounted for the largest market share while the service segment is forecasted to grow with a higher growth rate during 2022-2027.The service segment includes post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services. The service market segment is expected to register higher CAGR especially in matured markets like North America and Europe.
“The Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators subsegment ofLinear Accelerators, within the external beam radiotherapy, to register a significant growth rateduring the forecast period”
On the basis oftechnology, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy products. The external beam radiotherapy products segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units. The internal beam radiotherapy/brachytherapy products segment includes seeds, applicators, afterloaders, and IORT systems. The linear accelerators or LINAC segment is further characterized by conventional LINAC systems and stereotactic advanced electron/cobalt-60 LINAC systems. The Stereotactic advanced LINAC systems segment is expected to register the highest growth rate amongst linear accelerators segment. These systems provide precise 3D localization of the treatment target for various oncology procedures. The major objective of advanced LINAC systems is to expose the tumor to a single high dose of radiation while minimizing exposure to healthy surrounding structures. These systems can provide high precision and reduced treatment time with real-time tracking features which further supports the adoption of these systems.
“Continuous product development and launchesto drive the segment growthof particle therapy technology segment”
Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy. The particle therapy subsegment of external beam radiotherapy is expected to grow with the highest growth rate amongst other segments of external beam radiotherapy (including linear accelerators, and conventional cobalt-60 teletherapy units). Continuous product development and R&D activities are also driving the growth of this market segment. Several particle therapy products have been launched in the market in the last three years. For example, Varian Medical Systems, Inc. (US), now under Siemens Healthineers AG (Germany), launched the ProBeam 360° single-room proton therapy system in 2018 and introduced a multi-room configuration for the same product in 2019. In April 2020, P-Cure (Israel) received CE marking for the P-ARTIS System, enabling the company to market and sell the product in Europe.
“The China market, by region, is expected to grow with the highest growth rate in the global rdaiotherpay market during the forecast period of 2022-2027”
On the basis of region, the radiotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific held the third largest share of the global radiotherapy market in 2021. Within Asia Pacific, China is expected to grow with the highest CAGR during the forecast period. The growth of this market is primarily driven by the favorable healthcare reforms and investments in the country. Owing to the growth potential of the Chinese radiotherapy market, various players are undertaking strategic initiatives to strengthen their presence in the country. These players include Mevion Medical Systems, IBA, Accuray, and Varian, which entered into partnerships, licensing deals, agreements, and cooperation framework agreements with various end users and stakeholders in China, to increase market presence in the country..
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type:Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–10%, Director-level–76%, and Others–14%
• By Region:North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%
The dominant players in the global radiotherapy market are Siemens Healthineers AG (Germany), Elekta (Sweden) Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), Hitachi Ltd. (Japan), iCAD, Inc. (US), IsoRay, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), and ZEISS Group (Germany), among others.
Research Coverage
This report studies the radiotherapymarket based ontype, technology, procedure, application, end user, and region. It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration:Comprehensive information on the product portfolios offered by the top players in the radiotherapymarket
Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapymarket
Market Development:Comprehensive information on lucrative emerging regions
Market Diversification:Exhaustive information about new products, growing geographies, and recent developments in the radiotherapymarket
Competitive Assessment:In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
목차
TABLE OF CONTENTS
1 INTRODUCTION (Page No. – 26)
1.1 OBJECTIVES OF STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 GEOGRAPHIES COVERED
1.3.3 INCLUSIONS & EXCLUSIONS
1.3.4 YEARS CONSIDERED
1.4 CURRENCY USED
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. – 31)
2.1 RESEARCH APPROACH
FIGURE 1 RADIOTHERAPY MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARIES: RADIOTHERAPY MARKET
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL RADIOTHERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
FIGURE 7 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. – 40)
FIGURE 8 RADIOTHERAPY MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 10 EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PROCEDURE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 RADIOTHERAPY MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE RADIOTHERAPY MARKET
4 PREMIUM INSIGHTS (Page No. – 45)
4.1 RADIOTHERAPY MARKET OVERVIEW
FIGURE 14 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH
FIGURE 15 EXTERNAL BEAM RADIOTHERAPY MARKET, BY PROCEDURE, 2022 VS. 2027 (USD MILLION)
4.2 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2021)
FIGURE 16 LINEAR ACCELERATORS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
4.3 GEOGRAPHIC SNAPSHOT OF RADIOTHERAPY MARKET
FIGURE 17 CHINA REGISTERS HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. – 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Technological advancements
5.2.1.2 Increasing incidence of cancer worldwide
TABLE 1 PROJECTION FOR NEW CANCER CASES BASED ON IARC DATA
5.2.1.3 Awareness initiatives on the benefits of radiotherapy
5.2.1.4 Growing use of particle therapy for cancer treatment
TABLE 2 PARTICLE THERAPY FACILITIES IN CLINICAL OPERATION (AS OF MAY 2022)
5.2.2 RESTRAINTS
5.2.2.1 Inadequate healthcare infrastructure
5.2.2.2 Shortage of skilled oncologists and radiologists
5.2.2.3 High cost of radiotherapy devices
5.2.2.4 High complexities associated with radiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.3.2 Increasing public-private investments in cancer research
5.2.4 CHALLENGES
5.2.4.1 Difficulties in visualizing tumors during radiotherapy procedures
5.2.4.2 Risk of radiation exposure
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 3 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 THREAT OF NEW ENTRANTS
5.3.3 THREAT OF SUBSTITUTES
5.3.4 BARGAINING POWER OF SUPPLIERS
5.3.5 BARGAINING POWER OF BUYERS
5.3.6 DEGREE OF COMPETITION
5.4 REGULATORY SCENARIO
5.4.1 KEY REGULATORY BODIES & GOVERNMENT AGENCIES IN THE RADIOTHERAPY MARKET
TABLE 4 KEY REGULATORY BODIES & GOVERNMENT AGENCIES
5.4.2 KEY REGULATORY GUIDELINES
5.4.2.1 US
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2.2 Europe
5.4.2.3 Japan
TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.5 REIMBURSEMENT SCENARIO
TABLE 7 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITY
TABLE 8 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS. 2022
TABLE 9 OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT (2021 VS. 2022)
TABLE 10 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022
5.6 ECOSYSTEM COVERAGE
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 19 VALUE CHAIN ANALYSIS
5.8 SUPPLY-CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.8.3 END USERS
FIGURE 20 SUPPLY-CHAIN ANALYSIS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS
5.9.2 AVERAGE SELLING PRICE TREND
5.10 PATENT DETAILS
FIGURE 21 TOP 10 PATENT APPLICANTS FOR RADIOTHERAPY (JANUARY 2012–JUNE 2022)
FIGURE 22 TOP 10 PATENT INVENTORS FOR RADIOTHERAPY (JANUARY 2012–JUNE 2022)
FIGURE 23 TOP 10 PATENT OWNERS FOR RADIOTHERAPY (JANUARY 2012–JUNE 2022)
5.11 TRADE ANALYSIS
TABLE 11 IMPORT DATA FOR LINEAR ACCELERATORS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 12 EXPORT DATA FOR LINEAR ACCELERATORS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
5.12 TECHNOLOGY ANALYSIS
TABLE 13 IMPORTANT PRODUCT LAUNCHES IN THE RADIOTHERAPY MARKET (JANUARY 2015–JUNE 2022)
5.13 KEY CONFERENCES & EVENTS (2022–2023)
TABLE 14 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
FIGURE 24 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR RADIOTHERAPY SYSTEMS
TABLE 15 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR PRODUCT SEGMENTS (%)
5.16 KEY BUYING CRITERIA BY END USERS
TABLE 16 KEY BUYING CRITERIA FOR PRODUCT SEGMENTS
6 RADIOTHERAPY MARKET, BY TYPE (Page No. – 79)
6.1 INTRODUCTION
TABLE 17 RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 PRODUCT
6.2.1 LARGE UNTAPPED MARKETS IN EMERGING COUNTRIES DRIVE GROWTH
TABLE 18 PRODUCT MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SERVICE
6.3.1 LARGE INSTALLATION BASES IN MATURE MARKETS FUEL DEMAND FOR SERVICES
TABLE 19 SERVICE MARKET, BY REGION, 2020–2027 (USD MILLION)
7 RADIOTHERAPY MARKET, BY TECHNOLOGY (Page No. – 82)
7.1 INTRODUCTION
TABLE 20 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 21 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (UNITS INSTALLED)
7.2 EXTERNAL BEAM RADIOTHERAPY (EBRT)
TABLE 22 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 23 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (UNITS INSTALLED)
TABLE 24 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1 LINEAR ACCELERATORS
TABLE 25 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 26 LINEAR ACCELERATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1.1 Conventional linear accelerators
7.2.1.1.1 Longer treatment duration limits adoption
TABLE 27 CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1.2 Stereotactic advanced electron/cobalt-60 linear accelerators
TABLE 28 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 29 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1.2.1 CyberKnife
7.2.1.2.1.1 CyberKnife offers precise radiation delivery with robotic correction capabilities
TABLE 30 CYBERKNIFE MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1.2.2 Gamma Knife
7.2.1.2.2.1 Ongoing product development and launches support demand
TABLE 31 GAMMA KNIFE MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.1.2.3 TomoTherapy
7.2.1.2.3.1 High installation and maintenance costs limit adoption
TABLE 32 TOMOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.2 PARTICLE THERAPY SYSTEMS
TABLE 33 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 34 PARTICLE THERAPY SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.2.1 Cyclotrons
7.2.2.1.1 Cyclotrons deliver a continuous stream of particles to a tumor site, enhancing outcomes
TABLE 35 CYCLOTRONS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.2.2 Synchrotrons
7.2.2.2.1 Increasing investments in synchrotron facilities drive market
TABLE 36 SYNCHROTRONS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.2.3 Synchrocyclotrons
7.2.2.3.1 High space requirements limit widespread adoption
TABLE 37 SYNCHROCYCLOTRONS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.2.3 CONVENTIONAL COBALT-60 TELETHERAPY UNITS
7.2.3.1 Complex dose delivery planning and radiation exposure limit market adoption
TABLE 38 CONVENTIONAL COBALT-60 TELETHERAPY UNITS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 39 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 40 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.1 SEEDS
7.3.1.1 Adverse side-effects associated with seeds limit adoption
TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY SEEDS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.2 APPLICATORS
7.3.2.1 Manual applicators pose a high risk of radiation exposure
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.3 AFTERLOADERS
7.3.3.1 Proper positioning and better control of isotopes in modern afterloaders drive demand
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY AFTERLOADERS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3.4 IORT SYSTEMS
7.3.4.1 Rising adoption of electronic brachytherapy procedures supports growth
TABLE 44 IORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
7.4 SYSTEMIC RADIOTHERAPY
7.4.1 HIGH RISK OF RADIATION EXPOSURE LIMITS ADOPTION
7.4.2 IOBENGUANE (I-131)
7.4.3 SAMARIUM-153
7.4.4 RHENIUM-186
7.4.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS
8 RADIOTHERAPY MARKET, BY APPLICATION (Page No. – 104)
8.1 INTRODUCTION
TABLE 45 RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATION
TABLE 46 EXTERNAL BEAM RADIOTHERAPY APPLICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 47 EXTERNAL BEAM RADIOTHERAPY APPLICATION MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2.1 PROSTATE CANCER
8.2.1.1 High incidence rate and efficiency of EBRT for prostate cancer treatment support growth
TABLE 48 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2027 (USD MILLION)
8.2.2 BREAST CANCER
8.2.2.1 Therapeutic benefits of EBRT for breast cancer support market growth
TABLE 49 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020–2027 (USD MILLION)
8.2.3 LUNG CANCER
8.2.3.1 Radiotherapy can be used as adjuvant therapy for lung cancer
TABLE 50 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2020–2027 (USD MILLION)
8.2.4 HEAD & NECK CANCER
8.2.4.1 Noninvasiveness of EBRT in treatment of head & neck cancers drives growth
TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2020–2027 (USD MILLION)
8.2.5 COLORECTAL CANCER
8.2.5.1 High incidence of colorectal cancer to support market growth
TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2020–2027 (USD MILLION)
8.2.6 OTHER CANCERS
TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020–2027 (USD MILLION)
8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 54 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATION MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 55 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATION MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3.1 PROSTATE CANCER
8.3.1.1 Precision of brachytherapy drives market growth
TABLE 56 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.2 GYNECOLOGICAL CANCER
8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy
TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.3 BREAST CANCER
8.3.3.1 Brachytherapy is a replacement for traditional whole-breast external radiation therapy
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.4 CERVICAL CANCER
8.3.4.1 Combination treatment of brachytherapy and chemotherapy supports market growth
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.5 PENILE CANCER
8.3.5.1 Interstitial brachytherapy and plesiobrachytherapy are used in penile cancer treatment
TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2020–2027 (USD MILLION)
8.3.6 OTHER CANCERS
TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2020–2027 (USD MILLION)
9 RADIOTHERAPY MARKET, BY PROCEDURE (Page No. – 120)
9.1 INTRODUCTION
TABLE 62 RADIOTHERAPY MARKET, BY PROCEDURE, 2020–2027 (USD MILLION)
9.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 63 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3 IMAGE-GUIDED RADIOTHERAPY (IGRT)
9.3.1 IMAGE-GUIDED RADIOTHERAPY IS USED TO TREAT DEEP-SEATED TUMORS
TABLE 65 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3.2 INTENSITY-MODULATED RADIOTHERAPY
9.3.2.1 IMRT modulates radiation intensity and conforms radiation doses in a tumor
TABLE 66 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3.3 3D CONFORMAL RADIOTHERAPY
9.3.3.1 Multiple beams with 3D-CRT offer dose escalation within target volume
TABLE 67 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3.4 STEREOTACTIC THERAPY
9.3.4.1 Stereotactic therapy offers minimally invasive alternatives to ablation surgeries
TABLE 68 STEREOTACTIC THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3.5 PARTICLE THERAPY
9.3.5.1 Adoption of particle therapy as a primary mode of cancer treatment supports market growth
TABLE 69 PARTICLE THERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 70 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4.1 HIGH-DOSE-RATE BRACHYTHERAPY
9.4.1.1 HDR brachytherapy delivers radiation dose through temporarily positioned applicators
TABLE 72 HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4.2 LOW-DOSE-RATE BRACHYTHERAPY
9.4.2.1 Lower risk of radiation exposure to surrounding tissues drives market growth
TABLE 73 LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.4.3 PULSED-DOSE-RATE BRACHYTHERAPY
9.4.3.1 Pulsed-dose-rate brachytherapy combines benefits of HDR and LDR brachytherapy
TABLE 74 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
9.5 SYSTEMIC RADIOTHERAPY
9.5.1 HIGH COST OF RADIOPHARMACEUTICALS AND HIGH RISK OF RADIATION EXPOSURE LIMIT UTILIZATION OF THIS PROCEDURE
9.5.2 INTRAVENOUS RADIOTHERAPY
9.5.3 ORAL RADIOTHERAPY
9.5.4 INSTILLATION RADIOTHERAPY
10 RADIOTHERAPY MARKET, BY END USER (Page No. – 133)
10.1 INTRODUCTION
TABLE 75 RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2 HOSPITALS
10.2.1 GROWING ADOPTION OF RADIOTHERAPY PROCEDURES DRIVES MARKET GROWTH
TABLE 76 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
10.3 INDEPENDENT RADIOTHERAPY CENTERS
10.3.1 LOWER OPERATING COSTS AND CONVENIENCE SUPPORT MARKET GROWTH
TABLE 77 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2020–2027 (USD MILLION)
11 RADIOTHERAPY MARKET, BY REGION (Page No. – 137)
11.1 INTRODUCTION
TABLE 78 RADIOTHERAPY MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
TABLE 79 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 81 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 84 NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 88 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 89 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 US
11.2.1.1 Changes in reimbursement scenario to drive market growth
TABLE 91 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 92 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 US: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Cancer is a leading cause of death in Canada
TABLE 95 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 96 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 CANADA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3 EUROPE
TABLE 99 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 101 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 104 EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 110 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Availability of novel radiotherapy products drives market growth
TABLE 111 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 112 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 114 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 High purchasing & maintenance costs of advanced radiotherapy systems limit market growth
TABLE 115 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 116 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 117 FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 118 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3.3 UK
11.3.3.1 High healthcare expenditure drives market growth
TABLE 119 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 120 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3.4 SPAIN
11.3.4.1 Growing research activities on cancer care support market growth
TABLE 123 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 124 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 125 SPAIN: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 126 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3.5 ITALY
11.3.5.1 High number of oncology-specific clinical trials & studies support market growth
TABLE 127 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 128 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 ITALY: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 131 ROE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 132 ROE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 133 ROE: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 134 ROE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 136 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 137 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 138 ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 141 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 142 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 145 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 146 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Rising geriatric population and incidence of cancer drive market
TABLE 147 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 148 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 149 JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Growing partnerships among market players to support growth
TABLE 151 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 152 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 153 CHINA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 154 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4.3 INDIA
11.4.3.1 High need for radiotherapy systems to provide market opportunities
TABLE 155 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 156 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 INDIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4.4 SOUTH KOREA
11.4.4.1 Increasing incidence of cancer to support market
TABLE 159 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 160 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 161 SOUTH KOREA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Availability of funding for cancer care & research to drive growth
TABLE 163 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 164 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 AUSTRALIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.4.6 REST OF ASIA PACIFIC
TABLE 167 ROAPAC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 168 ROAPAC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 170 ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.5 LATIN AMERICA
TABLE 171 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 176 LATIN AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 178 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 181 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 182 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 Restricted affordability & access to radiotherapy treatment challenges market growth
TABLE 183 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 184 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 185 BRAZIL: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 186 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 Rising target population drives market growth in Mexico
TABLE 187 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 188 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 189 MEXICO: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 190 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 191 ROLATAM: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 192 ROLATAM: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 ROLATAM: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 194 ROLATAM: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH
TABLE 195 MEA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 196 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 197 MEA: LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 198 MEA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 199 MEA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 200 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 201 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 203 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 204 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 205 MEA: RADIOTHERAPY MARKET, BY END USER, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. – 201)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES
FIGURE 28 KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET (2019 TO 2022)
12.3 REVENUE SHARE ANALYSIS
FIGURE 29 REVENUE SHARE ANALYSIS OF THE TOP FIVE PLAYERS IN THE RADIOTHERAPY MARKET (2018–2021)
12.4 MARKET SHARE ANALYSIS: RADIOTHERAPY MARKET, BY KEY PLAYER (2021)
FIGURE 30 RADIOTHERAPY MARKET SHARE BY KEY PLAYER, 2021
TABLE 206 RADIOTHERAPY MARKET: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION QUADRANT FOR MAJOR PLAYERS (AS OF 2021)
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 31 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
12.6 START-UP/SMES EVALUATION QUADRANT (AS OF 2021)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 32 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
12.7 COMPETITIVE BENCHMARKING
TABLE 207 OVERALL FOOTPRINT ANALYSIS OF COMPANIES IN THE RADIOTHERAPY MARKET
TABLE 208 PRODUCT FOOTPRINT ANALYSIS OF THE COMPANIES IN THE RADIOTHERAPY MARKET
TABLE 209 REGIONAL FOOTPRINT ANALYSIS OF THE COMPANIES IN THE RADIOTHERAPY MARKET
12.8 COMPETITIVE SCENARIO (2019–2022)
12.8.1 PRODUCT LAUNCHES & APPROVALS
12.8.2 DEALS
12.8.3 OTHER DEVELOPMENTS
13 COMPANY PROFILES (Page No. – 216)
(Business overview, Products offered, Recent developments & MnM View)*
13.1 KEY PLAYERS
13.1.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 210 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
FIGURE 33 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
13.1.2 ELEKTA
TABLE 211 ELEKTA: BUSINESS OVERVIEW
FIGURE 34 ELEKTA: COMPANY SNAPSHOT (2021)
13.1.3 ACCURAY INCORPORATED
TABLE 212 ACCURAY INCORPORATED: BUSINESS OVERVIEW
FIGURE 35 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021)
13.1.4 IBA WORLDWIDE
TABLE 213 IBA: BUSINESS OVERVIEW
FIGURE 36 IBA: COMPANY SNAPSHOT (2021)
13.1.5 VIEWRAY TECHNOLOGIES, INC.
TABLE 214 VIEWRAY TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 37 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT
13.1.6 BD
TABLE 215 BD: BUSINESS OVERVIEW
FIGURE 38 BD: COMPANY SNAPSHOT (2021)
13.1.7 BEBIG MEDICAL
TABLE 216 BEBIG MEDICAL: BUSINESS OVERVIEW
13.1.8 HITACHI LTD.
TABLE 217 HITACHI LTD.: BUSINESS OVERVIEW
FIGURE 39 HITACHI LTD.: COMPANY SNAPSHOT (2021)
13.1.9 ICAD, INC.
TABLE 218 ICAD, INC.: BUSINESS OVERVIEW
FIGURE 40 ICAD, INC.: COMPANY SNAPSHOT (2021)
13.1.10 INTRAOP MEDICAL, INC.
TABLE 219 INTRAOP MEDICAL, INC.: BUSINESS OVERVIEW
13.1.11 ISORAY, INC.
TABLE 220 ISORAY, INC.: BUSINESS OVERVIEW
FIGURE 41 ISORAY, INC.: COMPANY SNAPSHOT (2021)
13.1.12 MEVION MEDICAL SYSTEMS
TABLE 221 MEVION MEDICAL SYSTEMS: BUSINESS OVERVIEW
13.1.13 OPTIVUS PROTON THERAPY, INC.
TABLE 222 OPTIVUS PROTON THERAPY: BUSINESS OVERVIEW
13.1.14 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 223 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
13.1.15 P-CURE
TABLE 224 P-CURE: BUSINESS OVERVIEW
13.1.16 PROVISION HEALTHCARE
TABLE 225 PROVISION HEALTHCARE: BUSINESS OVERVIEW
13.1.17 SENSUS HEALTHCARE
TABLE 226 SENSUS HEALTHCARE: BUSINESS OVERVIEW
FIGURE 42 SENSUS HEALTHCARE: COMPANY SNAPSHOT (2021)
13.1.18 SUMITOMO HEAVY INDUSTRY LTD.
TABLE 227 SUMITOMO HEAVY INDUSTRY LTD: BUSINESS OVERVIEW
FIGURE 43 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (2021)
13.1.19 THERAGENICS
TABLE 228 THERAGENICS CORPORATION: BUSINESS OVERVIEW
13.1.20 ZEISS GROUP
TABLE 229 ZEISS GROUP: BUSINESS OVERVIEW
FIGURE 44 ZEISS GROUP: COMPANY SNAPSHOT
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 ISOAID
13.2.2 MAGNETTX ONCOLOGY SOLUTIONS LTD.
13.2.3 PROTOM INTERNATIONAL
13.2.4 REFLEXION
13.2.5 S.I.T. SORDINA IORT TECHNOLOGIES S.P.A.
14 APPENDIX (Page No. – 283)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
